Fig. 3
From: Immune phenotype of patients with stage IV metastatic inflammatory breast cancer
Expression levels of CD16, granzyme B, and perforin in NK cell subsets from IBC patients compared to healthy controls. Expression levels CD56bright NK cells as measured by geometric mean fluorescence intensity (GMFI) for expression levels of a CD16 (FcγRIIIA), b granzyme B, and c perforin. Healthy donors are shown as open circles, triple-negative IBC patients as shaded triangles, untreated IBC patients as filled squares, and chemotherapy-treated IBC patients as open squares. Horizontal lines indicate median values and statistical significance was determined by a Wilcoxon rank-sum test